Abstract:What's new? There is a need to expand the use of non‐invasive or minimally invasive methods to identify patients with a high risk of colorectal cancer. In this three‐stage study, the levels of three pairs of serum microRNAs exhibited statistically significant differences between colorectal cancer patients and normal subjects. A serum microRNA panel that was formulated using the three microRNA pairs yielded a high accuracy in diagnosing colorectal cancer patients, with an AUC of approximately 0.9. The serum miRNA test is a feasible and promising non‐invasive biomarker‐based method for the diagnosis of colorectal cancer patients in comparison to normal subjects. Screening plays a crucial role in the early detection of colorectal cancer, greatly reducing mortality rates. The objective of this study was to identify a non‐invasive diagnostic method utilizing serum microRNA expression for the diagnosis of colorectal cancer patients. The study consisted of three stages. In the first stage, 129 patients with colorectal cancer and 129 normal subjects were recruited as the training set for the development of a blood miRNA panel. The second stage involved recruiting 200 patients from each group as the validation cohort. Finally, a blinded study was conducted in the third stage, with 260 patients recruited to determine the predictive value of our miRNA panel. Serum samples were prospectively collected from colorectal cancer patients and normal subjects between 2017 and 2021 at Queen Mary Hospital in Hong Kong. Quantitative PCR was utilized to detect the serum levels of candidate microRNAs, and a multiple linear regression model was employed to formulate a serum microRNA panel for diagnosing colorectal cancer patients. The performance of the panel was evaluated using ROC analysis. Our study showed that the values of three pairs of serum microRNAs, namely miR‐106b‐5p/miR‐1246, miR‐106b‐5p/miR‐16 and miR‐106b‐5p/miR‐21‐5p, exhibited statistically significant differences between colorectal cancer patients and normal subjects. A serum microRNA panel formulated from these three pairs of microRNAs demonstrated high accuracy in diagnosing colorectal cancer patients from normal subjects, with an AUC of approximately 0.9. The serum miRNA test proved to be a feasible and promising non‐invasive biomarker for the diagnosis of colorectal cancer patients in comparison to normal subjects.

MicroRNA‐206 has a bright application prospect in the diagnosis of cases with oral cancer

Expression and Clinical Significance of Serum MicroRNA -21 in Different Stage Lung Carcinoma and in Pulmonary Bulla Patients

Circulating Microrna-21 As a Potential Diagnostic Marker for Colorectal Cancer: A Meta-Analysis.

High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer

Identification of Serum Circulating MicroRNAs as Novel Diagnostic Biomarkers of Gastric Cancer

Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.

The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors

Identification and evaluation of a serum microRNA panel to diagnose colorectal cancer patients

Identification of Serum Mirnas by Nano-Quantum Dots Microarray As Diagnostic Biomarkers for Early Detection of Non-Small Cell Lung Cancer

The diagnostic and prognostic values of microRNA-196a in cancer

The clinical use of circulating microRNAs as non-invasive diagnostic biomarkers for lung cancers.

A novel microRNA miR-4433a-3p as a potential diagnostic biomarker for lung adenocarcinoma

Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients.

Expression Profile Of Circulating Micrornas As A Promising Fingerprint For Cervical Cancer Diagnosis And Monitoringy

MicroRNA-206 overexpression is associated with a prominent inflammatory reaction and a favorable colorectal cancer prognosis

MicroRNA biomarkers and their use in evaluating the prognosis of lung cancer

Reduced Serum Mir-138 is Associated with Poor Prognosis of Head and Neck Squamous Cell Carcinoma

Serum Mir-21 and Mir-210 As Promising Non-Invasive Biomarkers for the Diagnosis and Prognosis of Colorectal Cancer

Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.

Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma

MiR ‐205‐5p promotes lung cancer progression and is valuable for the diagnosis of lung cancer